HWM
JAZZ icon

HB Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

HB Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$897K Buy
3,722
+812
+28% +$178K 0.01% 795
2026
Q1 		$550K Buy
2,910
+626
+27% +$109K ﹤0.01% 928
2025
Q4 		$388K Buy
2,284
+226
+11% +$34.6K ﹤0.01% 1011
2025
Q3 		$271K Buy
+2,058
New +$247K ﹤0.01% 1126

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

HB Wealth Management's JAZZ Position: Q2 2026 in Review

HB Wealth Management increased its Jazz Pharmaceuticals (JAZZ) stake by 28% in Q2 2026, buying an estimated $178K and bringing the position to 3,722 shares worth $897K. The position accounts for 0.01% of the portfolio, ranked #795.

HB Wealth Management first reported a position in JAZZ in Q3 2025 and has held it in 4 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • HB Wealth Management held 3,722 shares of Jazz Pharmaceuticals worth $897K as of Q2 2026.
  • HB Wealth Management bought 812 Jazz Pharmaceuticals shares in Q2 2026, an estimated $178K.
  • Jazz Pharmaceuticals made up 0.01% of HB Wealth Management's portfolio in Q2 2026, its #795 holding.
  • HB Wealth Management first reported a position in Jazz Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.